|
Company Upgrade: Introduces Healthways to our Bluechips Portfolio
(M2 PressWIRE Via Thomson Dialog NewsEdge)
RDATE:07032008
International Stock Targets is a world renowned independent research
firm, based in Johannesburg, South Africa. Along with walking investors
through the whole life-cycle of many different equities, we have also
partnered with the top independent research firms worldwide to provide
our members with the best knowledge to make money. Click the link below
to see a sample of a recent "Buy Recommendation" that was issued on a
small-cap equity that we believe is positioned to out-perform their
competitors. We highly recommend that all interested small-cap
investors sign up to www.internationalstocktargets.com for a free 3
month subscription and contact one of our representatives toll free 1
866 657 3334 to get access to our "small-cap" stock pick of the year.
On Friday, March 7th, 2008, Healthways (NASDAQ: HWAY) had a news
release that triggered our research mechanism sensors at International
Stock Targets. We therefore have also added Healthways to our Bluechips
Portfolio, their recent market activity has made them a possible
candidate for a full analytical research report, to see a sample of our
newest report view this link.
http://www.internationalstocktargets.com/Jan_2007_Target_Report.pdf
Investors looking to get a free stock report on any equity they have in
their portfolio are also asked to sign up to
www.internationalstocktargets.com for a free 3 month subscription. It's
easy, free, and no credit card is needed. Our analysts will supply free
stock reports for any equity trading on the NYSE, NASDAQ, AMEX, TSX,
TSX Venture and US Small-Cap Markets. Enjoy this limited time offer for
free.
For future reports on Healthways and other growth stocks sign up to
www.internationalstocktargets.com for a 3 month trial subscription.
"We at international stock targets have made it our goal to partner
with as many of the top research firms and analysts to provide you the
investors top quality research. Becoming a member to
www.internationalstocktargets.com will give you free access to many
different investment reports including analysis of most of the
companies you hold in your portfolio. See how working with us today can
expand your net worth tomorrow," Stefen Gorgin CEO and Head Analyst
International Stock Targets
Healthways closed slightly down 0.85 percent on Thursday with a volume
over 1,400,000.
On Friday, March 7th, 2008, The Gallup-Healthways Well announced by
Gallup chairman and CEO Jim Clifton, and Healthways president and CEO
Ben R. Leedle, Jr. The exclusive 25-year strategic relationship between
Gallup and Healthways resulted from their membership in former House
Speaker Newt Gingrich's Center for Health Transformation.
Data collection for the Index will be based on 1,000 daily surveys
which Gallup polling experts began conducting in January and which will
continue throughout the 25-year term of the agreement. Armed with this
unprecedented depth of information, leaders across government and
business will be able to collaboratively and more effectively address
the health, wellness and prevention needs of their population.
Similarly, business leaders will be better guided in implementing
programs to unlock the productivity dollars currently being lost to
health-related causes.
About us:
International Stock Targets is a world renowned research firm,
specializing in identifying undervalued growth companies and walking
members through the life-cycle of an equity's most aggressive growth
periods. IST has been honoured the "Best International Research Team
Award" three years in a row, and has been praised in many of the top
publications globally and is recognized for their research, accuracy
and professionalism.
Information contained in this release was extracted from publicly
available sources deemed reliable. This document may contain
forward-looking statements, particularly as related to the business
plans of the Companies, within the meaning of Section 27A of the
Securities Act of 1933 and Sections 21E of the Securities Exchange Act
of 1934, and are subject to the safe harbor created by these sections.
Actual results may differ materially from the Company's expectations
and estimates. The companies mentioned in this publication have not
approved the content or timing of the information being published
unless otherwise noted. No investor should assume that reliance on the
views, opinions or recommendations contained herein will produce
profitable results. International Stock Targets may hold positions in
securities mentioned herein, and may make purchases or sales in such
securities featured on our web site or within our reports.
International Stock Targets may at some time effect transactions in the
securities mentioned. Additional information is available upon request
subject to duties of confidentiality. The report has been compiled for
information purposes only and under no circumstances should be
considered as a solicitation to buy or sell any securities or as
investment advice. While the information contained herein has been
obtained from sources we believe to be reliable, International Stock
targets does not represent or warrant the accuracy or completeness of
the report. Independent investment advice should be sought before
relying on any research regarding a specific company. Risk factors and
actual results may differ significantly from the information contained
in the report. International Stock Targets have not received
compensation for this coverage and is not affiliated with the Company
mentioned in this report. Target Prices are based on our own
proprietary methods and should not be considered as all-inclusive nor
considered as price projections based on revenue or performance. We
strongly advise seeking professional investment advice.
CONTACT: International Stock Targets
Tel: +1 866 657 3334 (toll free)
WWW: http://www.internationalstocktargets.com
((M2 Communications Ltd disclaims all liability for information
provided within M2 PressWIRE. Data supplied by named party/parties.
Further information on M2 PressWIRE can be obtained at
http://www.presswire.net on the world wide web. Inquiries to
info@m2.com)).
Copyright ? 2008 M2 Communications Ltd.
[ Back To TMCnet.com's Homepage ]
|
